CLVS Stock Climbs 18%+: Here’s Why

Clover Health Investments CLOV Stock News

Clovis Oncology Inc (NASDAQ: CLVS) is headed for the top in the market this morning after presenting data. The data demonstrated strong efficacy and safety of the company’s flagship candidate, Rubraca.  Here’s what’s happening: Clovis Oncology Announces Positive Data In the press release, Clovis oncology announced the first presentation of data from its Phase 3 … Read more

Clovis Oncology (CLVS) Stock: Headed For The Top On Clinical Data

Clovis Oncology Inc (NASDAQ: CLVS) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced initial data from an ongoing Phase 2 clinical trial that proved to be positive. Of course, the data led to excitement among investors who are now sending … Read more

Clovis Oncology (CLVS) Stock: Soaring On Breakthrough Therapy Designation

Clovis Oncology Inc (NASDAQ: CLVS) is having an incredibly strong start to the trading session this morning, and for good reason. The company’s flagship candidate has been granted Breakthrough Therapy designation by the FDA. Of course, the news excited investors, sending the stock screaming for the top. Today, we’ll talk about: The designation; what we’re … Read more

Clovis Oncology (CLVS) Stock: Here’s Why It’s Up

Clovis Oncology Inc (NASDAQ: CLVS) is having an overwhelmingly strong start to the trading session this morning, and for good reason. In a press release issued late in after-hours yesterday, the company announced that it has received a positive vote with regard to regulatory approval in Europe. Today, we’ll talk about the news, what we’re seeing … Read more

Clovis Oncology (CLVS) Stock: Gaining On Positive Clinical Data

Clovis Oncology Inc (NASDAQ: CLVS) is off to an incredibly strong start to the trading session this morning, and for good reason. The company released positive clinical data surrounding rucaparib. Of course, this led to excitement among investors, causing gains and prompting our partners at Trade Ideas to alert us to the movement. At the … Read more

Clovis Oncology (CLVS) Declines On FDA Information Request

Clovis Oncology Inc (NASDAQ: CLVS) Clovis Oncology is having an incredibly hard time in the market today after announcing that the FDA has requested more information with regard to the efficacy analysis for an experimental treatment. Today, we’ll discuss the FDA’s request, the announcement CLVS made with regard to the request, and what we can … Read more